Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
1995-9-5
|
pubmed:abstractText |
Fumonisin B2 (FB2), a secondary metabolite of the fungus Fusarium moniliforme, was administered at a dose of 7.5 mg/kg body weight to male BD IX rats by ip injection or by gavage. FB2 was rapidly absorbed from the peritoneum, its level in plasma reaching a maximum within 20 min after injection. It was rapidly eliminated from plasma with a half-life of 26 min. After 24 hr, FB2 could not be detected in plasma (< 20 ng/ml). Analysis of rat plasma for FB2 following a gavage dose failed to detect any toxin over a 6-hr period after dosing. The elimination of FB2 in the urine and faeces was determined over a 3-day period after dosing. After i.p. injection, the mean urinary excretion over this period was 1.2% and faecal elimination accounted for 84.1% of the dose. Similarly, after dosing by gavage, 0.2 and 82.0% of the dose was recovered in urine and faeces, respectively. FB2 appeared to be excreted unmetabolized.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0278-6915
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
33
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
591-5
|
pubmed:dateRevised |
2006-3-13
|
pubmed:meshHeading |
pubmed-meshheading:7628795-Absorption,
pubmed-meshheading:7628795-Administration, Oral,
pubmed-meshheading:7628795-Animals,
pubmed-meshheading:7628795-Carcinogens, Environmental,
pubmed-meshheading:7628795-Chromatography, High Pressure Liquid,
pubmed-meshheading:7628795-Feces,
pubmed-meshheading:7628795-Fumonisins,
pubmed-meshheading:7628795-Half-Life,
pubmed-meshheading:7628795-Injections, Intraperitoneal,
pubmed-meshheading:7628795-Male,
pubmed-meshheading:7628795-Mycotoxins,
pubmed-meshheading:7628795-Rats
|
pubmed:year |
1995
|
pubmed:articleTitle |
Toxicokinetics of the mycotoxin fumonisin B2 in rats.
|
pubmed:affiliation |
Programme on Mycotoxins and Experimental Carcinogenesis, Medical Research Council, Tygerberg, South Africa.
|
pubmed:publicationType |
Journal Article
|